Advertisement
Research Summary
Research Summary
04/24/2024

Anthony Calabro, MA

Anthony Calabro, MA
Researchers collected data from the Atherosclerosis Risk in Communities Study to determine whether heart rate variability was associated with agitation risk in individuals clinically diagnosed with dementia...
04/24/2024
FDA Alert
FDA Alert
04/18/2024

Anthony Calabro, MA

Anthony Calabro, MA
The FDA approved givinostat, a nonsteroidal oral medication, for treating patients 6 years of age or older with Duchenne muscular dystrophy.
04/18/2024
Research Summary
Research Summary
04/15/2024

Anthony Calabro, MA

Anthony Calabro, MA
Researchers set out to determine whether microglial activation, which can trigger neuroinflammation, is associated with neuropsychiatric symptoms that often accompany Alzheimer-associated dementias,...
04/15/2024
Research summary
Research summary
04/02/2024

Jessica Ganga

Jessica Ganga
Researchers sought to determine an association between people with hearing loss, their hearing aid use, and the possibility of an increased risk of dementia or Alzheimer disease.
04/02/2024
Research Summary
Research Summary
03/28/2024

Jessica Ganga

Jessica Ganga
Researchers investigated whether survivors of stroke could take two common types of antidepressant medications—SSRIs and SNRIs—and evaluated if serious bleeding occurred among patients. Their findings were...
03/28/2024
Research Summary
Research Summary
03/14/2024

Jessica Ganga

Jessica Ganga
A diverse team of experts representing the National Association of Epilepsy Centers updated a set of guidelines and recommendations for the care of patients with epilepsy.
03/14/2024
Research Summary
Research Summary
01/25/2024

Jessica Ganga

Jessica Ganga
Researchers sought to determine the effect of hearing interventions to reduce the risk of cognitive decline in older adults with hearing loss.
01/25/2024
FDA alert
FDA alert
11/14/2023

Jessica Ganga

Jessica Ganga
The FDA has approved the first biosimilar treatment for patients living with relapsing forms of multiple sclerosis.
11/14/2023
research summary
research summary
09/21/2023

Leigh Precopio

Leigh Precopio
A new expert consensus was released by the American Academy of Neurology reviewing the currently available evidence on the efficacy and safety of antiamyloid monoclonal antibodies for the treatment of...
09/21/2023
Research Summary
Research Summary
09/07/2023

Anthony Calabro, MA

Anthony Calabro, MA
Researchers found that patients taking suvorexant had reduced levels of amyloid beta and tau phosphorylation, proteins that play a major role in neurodegeneration in Alzheimer disease.
09/07/2023